KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Bausch Health Companies (BHC) Equity Average (2016 - 2025)

Bausch Health Companies' Equity Average history spans 16 years, with the latest figure at -$94.0 million for Q4 2025.

  • For Q4 2025, Equity Average rose 87.64% year-over-year to -$94.0 million; the TTM value through Dec 2025 reached -$94.0 million, up 87.64%, while the annual FY2025 figure was -$451.0 million, 60.8% up from the prior year.
  • Equity Average for Q4 2025 was -$94.0 million at Bausch Health Companies, up from -$209.0 million in the prior quarter.
  • Across five years, Equity Average topped out at $346.5 million in Q4 2022 and bottomed at -$760.5 million in Q4 2024.
  • The 5-year median for Equity Average is -$90.8 million (2022), against an average of -$151.4 million.
  • The largest annual shift saw Equity Average soared 510.06% in 2022 before it crashed 1402.78% in 2024.
  • A 5-year view of Equity Average shows it stood at -$84.5 million in 2021, then skyrocketed by 510.06% to $346.5 million in 2022, then plummeted by 281.39% to -$628.5 million in 2023, then fell by 21.0% to -$760.5 million in 2024, then skyrocketed by 87.64% to -$94.0 million in 2025.
  • Per Business Quant, the three most recent readings for BHC's Equity Average are -$94.0 million (Q4 2025), -$209.0 million (Q3 2025), and -$46.5 million (Q2 2025).